Index
Module 2 • Research Methods
Research Design, Biostatistics & Literature Evaluation
75%
Data Tables
Research Design, Biostatistics & Literature Evaluation
Julie E. Farrar ~3 min read Module 2 of 20
24
/ 32

Research Design, Biostatistics, and Literature Evaluation

Can aid in determining short-term goals. Example: Selecting an initial dose of loop diuretic

according to the home medication dose and current therapeutic goal of urinary output

Primary literature on which to base treatment decisions for all clinical scenarios may not exist.

B.Synthesizing the Available Evidence to Develop Treatment Protocols
1

Protocols are intended to synthesize the best available evidence and standardize a series of treatment

options to reduce variability and error while maximizing treatment effect. Examples: Sterile technique

for central line placement, heparin or insulin infusions, and sepsis bundles.

2Determining which literature to incorporate and its applicability to the local practice environment

is key.

3

Determine the homogeneity of various studies on the same topic (e.g., early goal-directed therapy

for septic shock) and confounding variables that influence the interpretation of results. Study design

affecting the screening and time to treatment for subjects compared with actual practice, improvements

in the processes of usual care over time, etc.

C.Unique Factors That Promote/Impede the Application of Treatment Protocols
1

Resource use

Personnel (e.g., Lancet 2010;375:475-80)

Drug shortages

Fiscal

2Ease of protocols

Complexity

Familiarity

3

Lack of consensus (e.g., sepsis 1-hour bundle)

Practice Case

Questions 7 and 8 pertain to the following case.

You are reading a study that evaluated the use of hydrocortisone versus placebo for lowering C-reactive protein

(CRP) in patients with ARDS at 3 days after enrollment. The authors concluded that they would need to enroll

100 patients to achieve 90% power to find a decrease in CRP of 10 mg/L, assuming a baseline concentration of

35 mg/L and an ฮฑ level of 0.05. They enroll 50 patients in the hydrocortisone group and 51 patients in the pla-

cebo group. The median [interquartile range] CRP concentrations in the intervention and placebo groups are 23

[19โ€“31] and 29 [20โ€“40], respectively (p<0.05). The percentages of patients achieving a CRP decrease of at least

10 mg/L in the intervention and placebo groups are 15% and 18%, respectively (p>0.05).

7

Which is your biggest concern with interpreting the validity of this study?

A.The study did not meet statistical power.
B.The sample size is too small to provide a representative population for the disease state.
C.The outcome of lowering CRP should not be dichotomized, but only analyzed as a continuous variable.
D.The outcome of CRP is a surrogate and likely not a good representation of the clinical implications of

steroid use in ARDS.

8

Which best describes the NNT for achieving a CRP decrease of at least 10 mg/L in this study?

A.34.
B.17.
C.50.
D.6.
HD Video Explanation โ€” Synchronized with PDF
Starts at: minute 23 Open on YouTube